Literature DB >> 24654805

Mefenamic acid anti-inflammatory drug: probing its polymorphs by vibrational (IR and Raman) and solid-state NMR spectroscopies.

Vanessa R R Cunha1, Celly M S Izumi, Philippe A D Petersen, Alviclér Magalhães, Marcia L A Temperini, Helena M Petrilli, Vera R L Constantino.   

Abstract

This work deals with the spectroscopic (supported by quantum chemistry calculations), structural, and morphological characterization of mefenamic acid (2-[(2,3-(dimethylphenyl)amino] benzoic acid) polymorphs, known as forms I and II. Polymorph I was obtained by recrystallization in ethanol, while form II was reached by heating form I up to 175 °C, to promote the solid phase transition. Experimental and theoretical vibrational band assignments were performed considering the presence of centrosymmetric dimers. Besides band shifts in the 3345-3310 cm(-1) range, important vibrational modes to distinguish the polymorphs are related to out-of-phase and in-phase N-H bending at 1582 (Raman)/1577 (IR) cm(-1) and 1575 (Raman)/1568 (IR) cm(-1) for forms I and II, respectively. In IR spectra, bands assigned to N-H bending out of plane are observed at 626 and 575 cm(-1) for polymorphs I and II, respectively. Solid-state (13)C NMR spectra pointed out distinct chemical shifts for the dimethylphenyl group: 135.8 to 127.6 ppm (carbon bonded to N) and 139.4 to 143.3 ppm (carbon bonded to methyl group) for forms I and II, respectively.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24654805     DOI: 10.1021/jp500988k

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  3 in total

1.  Quantum Chemical Study on Mefenamic Acid Polymorphic Forms.

Authors:  Svitlana V Shishkina; Yevhenii A Vaksler; Irina S Konovalova; Victoriya V Dyakonenko; Victoriya V Varchenko
Journal:  ACS Omega       Date:  2022-05-16

2.  Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics.

Authors:  Liang-Hui Chu; Brian H Annex; Aleksander S Popel
Journal:  Front Pharmacol       Date:  2015-08-25       Impact factor: 5.810

3.  Solubility enhancement of mefenamic acid by inclusion complex with β-cyclodextrin: in silico modelling, formulation, characterisation, and in vitro studies.

Authors:  Dounia Sid; Milad Baitiche; Zineb Elbahri; Ferhat Djerboua; Mokhtar Boutahala; Zouhair Bouaziz; Marc Le Borgne
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.